1. BSA-stabilized selenium nanoparticles ameliorate intracerebral hemorrhage's-like pathology by inhibiting ferroptosis-mediated neurotoxicology via Nrf2/GPX4 axis activation.
- Author
-
Li XN, Lin L, Li XW, Zhu Q, Xie ZY, Hu YZ, Long QS, Wei XB, Wen YQ, Zhang LY, Zhang QK, Jing YC, Wei XH, and Li XS
- Subjects
- Animals, Humans, Male, Mice, Disease Models, Animal, Membrane Potential, Mitochondrial drug effects, Mitochondria metabolism, Mitochondria drug effects, Neurons metabolism, Neurons drug effects, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Neuroprotective Agents administration & dosage, Serum Albumin, Bovine chemistry, Cerebral Hemorrhage drug therapy, Cerebral Hemorrhage metabolism, Ferroptosis drug effects, Nanoparticles chemistry, NF-E2-Related Factor 2 metabolism, Phospholipid Hydroperoxide Glutathione Peroxidase metabolism, Selenium chemistry, Selenium pharmacology
- Abstract
Intracerebral hemorrhage (ICH) is a prevalent hemorrhagic cerebrovascular emergency. Alleviating neurological damage in the early stages of ICH is critical for enhancing patient prognosis and survival rate. A novel form of cell death called ferroptosis is intimately linked to hemorrhage-induced brain tissue injury. Although studies have demonstrated the significant preventive impact of bovine serum albumin-stabilized selenium nanoparticles (BSA-SeNPs) against disorders connected to the neurological system, the neuroprotective effect on the hemorrhage stroke and the mechanism remain unknown. Therefore, based on the favorable biocompatibility of BSA-SeNPs, h-ICH (hippocampus-intracerebral hemorrhage) model was constructed to perform BSA-SeNPs therapy. As expected, these BSA-SeNPs could effectively improve the cognitive deficits and ameliorate the damage of hippocampal neuron. Furthermore, BSA-SeNPs reverse the morphology of mitochondria and enhanced the mitochondrial function, evidenced by mitochondrial respiration function (OCR) and mitochondrial membrane potential (MMP). Mechanistically, BSA-SeNPs could efficiently activate the Nrf2 to enhance the expression of antioxidant GPX4 at mRNA and protein levels, and further inhibit lipid peroxidation production in erastin-induced ferroptotic damages. Taken together, this study not only sheds light on the clinical application of BSA-SeNPs, but also provides its newly theoretical support for the strategy of the intervention and treatment of neurological impairment following ICH., Competing Interests: Declaration of competing interest All authors declare that there are no competing interests., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF